About this trial
This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Syndrome (ENS), which includes an alternative form of nasal obstruction. ART is a non-invasive treatment that uses sound vibrations to improve nasal congestion and other sinus symptoms. ART works by delivering specific frequencies of sound to the sinonasal cavities (nose and sinuses). These vibrations cause the tissues in the sinuses to resonate, which can help break up mucus and clear blockages, reduce inflammation, and improve airflow.
Eligibility criteria
Qualifiers
Documented case of Empty Nose Syndrome
Documented past turbinate reduction surgery
Disqualifiers
Neurocognitive diagnosis/decline
Trial design
Treatments tested in this trial
- Personalized ART
- Non-personalized ART
Treatment groups
Sponsors and collaborators
Stanford University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator